291 related articles for article (PubMed ID: 7507038)
1. Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness.
Wilde MI; Plosker GL; Benfield P
Drugs; 1993 Nov; 46(5):895-924. PubMed ID: 7507038
[TBL] [Abstract][Full Text] [Related]
2. Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
Milne RJ; Goa KL
Drugs; 1991 Mar; 41(3):450-77. PubMed ID: 1711447
[TBL] [Abstract][Full Text] [Related]
3. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
Grimsley SR; Jann MW
Clin Pharm; 1992 Nov; 11(11):930-57. PubMed ID: 1464219
[TBL] [Abstract][Full Text] [Related]
4. Moclobemide. A review of its pharmacological properties and therapeutic use in depressive illness.
Fitton A; Faulds D; Goa KL
Drugs; 1992 Apr; 43(4):561-96. PubMed ID: 1377119
[TBL] [Abstract][Full Text] [Related]
5. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
[TBL] [Abstract][Full Text] [Related]
6. Tianeptine: a review of its use in depressive disorders.
Wagstaff AJ; Ormrod D; Spencer CM
CNS Drugs; 2001; 15(3):231-59. PubMed ID: 11463130
[TBL] [Abstract][Full Text] [Related]
7. Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.
Figgitt DP; McClellan KJ
Drugs; 2000 Oct; 60(4):925-54. PubMed ID: 11085201
[TBL] [Abstract][Full Text] [Related]
8. Lofepramine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
Lancaster SG; Gonzalez JP
Drugs; 1989 Feb; 37(2):123-40. PubMed ID: 2649353
[TBL] [Abstract][Full Text] [Related]
9. Milnacipran. A review of its use in depression.
Spencer CM; Wilde MI
Drugs; 1998 Sep; 56(3):405-27. PubMed ID: 9777315
[TBL] [Abstract][Full Text] [Related]
10. Dothiepin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
Lancaster SG; Gonzalez JP
Drugs; 1989 Jul; 38(1):123-47. PubMed ID: 2670509
[TBL] [Abstract][Full Text] [Related]
11. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
Dechant KL; Clissold SP
Drugs; 1991 Feb; 41(2):225-53. PubMed ID: 1709852
[TBL] [Abstract][Full Text] [Related]
12. Fluvoxamine and tricyclic antidepressants (TCAs): how do the TCAs compare as "new" drugs with established fluvoxamine?
Ashford JJ
Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():27-31. PubMed ID: 7622820
[TBL] [Abstract][Full Text] [Related]
13. Fluvoxamine in the treatment of depressive illness. A series of double-blind hospital based comparative studies carried out in the UK.
Whitehead AM; Ashford JJ
Br J Clin Pract; 1992; 46(1):21-3. PubMed ID: 1419548
[TBL] [Abstract][Full Text] [Related]
14. Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
Benfield P; Ward A
Drugs; 1986 Oct; 32(4):313-34. PubMed ID: 3096686
[TBL] [Abstract][Full Text] [Related]
15. A review of fluvoxamine and its uses in depression.
Burton SW
Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():1-17; discussion 17-21. PubMed ID: 1806631
[TBL] [Abstract][Full Text] [Related]
16. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
Davis R; Wilde MI
CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050
[TBL] [Abstract][Full Text] [Related]
17. Fluvoxamine: a review of the controlled trials in depression.
Ware MR
J Clin Psychiatry; 1997; 58 Suppl 5():15-23. PubMed ID: 9184623
[TBL] [Abstract][Full Text] [Related]
18. Fluvoxamine and clomipramine in depressed hospitalised patients: results from a randomised, double-blind study.
Ottevanger EA
Encephale; 1995; 21(4):317-21. PubMed ID: 7588171
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of moclobemide compared with fluvoxamine in depressive disorder (DSM III). A French/Swiss double-blind trial.
Bougerol T; Uchida C; Gachoud JP; Köhler M; Mikkelsen H
Psychopharmacology (Berl); 1992; 106 Suppl():S102-8. PubMed ID: 1546121
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of antidepressants.
Kasper S; Fuger J; Möller HJ
Drugs; 1992; 43 Suppl 2():11-22; discussion 22-3. PubMed ID: 1378369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
